In 10 anaesthetized cats, electroretinographic (ERG) measurements were carried out to further elucidate the involvement of bradykinin as a substrate component of the renin-angiotensin system in retinal neurotransmission. Reducing angiotensin II concentration by angiotensin-converting enzyme (ACE) inhibition increased sensitivity [0.5 log units) and gain (50%) of the rod b-wave amplitnde. The b-wave implicit time was decreased only at high stimulus intensities (>10-2 cd/m), Blocking bradytdnin receptors specifically decreased rod b-wave implicit time for all intensities, while its amplitude remained unaffected. Bradykinin effects were independent of alterations of angiotensin II activity. We therefore suggest that bradyldnin influences inner retinal signal processing, hereby further supporting the hypothesis of a renin-angiotensin system involvement in retinal neurotransmission. Copyright K) 1996
INTRODUCTION
Bradykinin (BK) is a nonapeptidewith a wide range of actionsthat have been extensivelyinvestigatedin isolated organs, including the retina (Erdos, 1989; Taylor et al., 1989) . BK is known to influence vascular permeability, tonus of smooth muscle cells and by activation of phospholipase-A2, BK has also been shown to be a potent stimulator of prostaglandin and leukotriene synthesis (Griesbacher & Lembeck, 1989; Zusmann, 1987) . By stimulating nociceptive afferent nerve fibres BK enhances pain and hyperalgesia (Steranka et al., 1987) . However, not much is known whether BK-as many other peripherally active peptides-is also involved in modulatingneuronalactivity,more specifically in retinal neurotransmission.
BK is inactivated by the angiotensin converting enzyme (ACE) and thus closely related to the reninangiotensin system (Fig. 1) . Recent studies have suggested that various components of the renin-angiotensin system(RAS) are involvedin modulatingneuronal activity in the central nervous system (Severs & DanielsSevers, 1973; Brecha, 1983; Brecha et al., 1981; Felix, *Towhom all correspondenceshould be addressed at the Department of Ophthalmology, University Eye Hospital Cologne, JosephStelzmannstr. 9, 50931 Cologne,Germany. Departmentof Pharmacology,University of Tuebingen,Wilhelmstr.
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1982; Kolb & Nelson, 1983; Lind et al., 1985; Sessle & Henry, 1987; Story & Ziogas, 1987; Watt & Su, 1988; Morgan, 1989; Morgan et al., 1989; Ferrari-Dileo et al., 1988) . Moreover, immunocytochemicaland electroretinographical data provided experimental evidence of the RAS also participating in retinal neuromodulation (Dahlheim et al., 1988; Mallorga et al., 1989; Zrenner et al., 1989; Kohler et al., 1992; Jurklies et al., 1993; Jacobi et al., 1992 Jacobi et al., , 1994 Kaelin et al., 1994) .A possiblerole of BK in retinalphysiologyhas so far not been investigated. Recent experiments revealed that inhibition of ACE induces changes of electroretinographicpotentials originating in the inner retina, while outer retina signals remainunaffected (Jacobiet al., 1992 (Jacobiet al., ,1994 .To a certain extent some of these effects were reversible on angiotensin-11(ANGII) substitution, thus indicating an ANGII-mediated influenceon ERG responses (Jacobi et al., , 1994 . However, blocking ACE action simultaneously changes the metabolism of other peptides, including BK (Fig. 1) . As ACE catalyses both substrates-it increases the formation of ANGII but inactivatesBK-it seems difficultto assign the observed effects of ACE inhibitionto a single substrate.
The aim of this study was to further elucidate a possibleANGII influencefrom a BK-mediated effect on the electroretinogram(ERG)in anaesthesized cats. For this reason we applied a specific BK receptor antagonist (Hoeldo)prior to ACE inhibition(Quinapril).An increase in BK concentration following ACE inhibition should then have no neurobiochemicalinfluenceat the receptor site. The pharmacokinetics and -dynamics of ANGII, however, are not influencedby preceding application of the BK receptor blocker. We can, therefore, assume that differences in effects on ERG responses of single ACE inhibition on the one hand, and of ACE inhibition in conjunctionwith BK receptor blockade on the other may be due to a BK-mediated action. Since bradykinincan be shown to have a specific influence on electroretinographic responses, this study provides further evidence for the involvementof the RAS in retinal neuromodulation.
METHODS
Preparations and recordings were carried out as described in detail previously (Jacobi et al., 1994) . All animals were treated according to the resolution of the European CommunitiesCouncil Directive (1986) on the Use of Animals in Research.Anesthesia was initiatedby an i.m. injection of ketamine and thiamine hydrochloride (3:2; 0.15 mg/kg) in 10 adult cats. Animals were then intubated and carefully monitored for respiration and circulation parameters. Arterial blood pressure was monitored on-line by means of a femoral artery catheter. A femoral" vein catheter was used'for iv. drug application. By repeated intravenous injections (0.1 ml) of pentobarbital (Nembutal 60 mg/ml) the maintainanceof anesthesia was ensured.
The ERG was recorded by means of corneal contact lens electrodes (ERG Jet Electrode) with pupils fully dilated. Subdermal electrodesplaced at the forehead and the front leg served as indifferentand ground electrodes, respectively. The luminance of a Ganzfeld-stimulator (LKC, Utas 2000) was attenuated by neutral density filters (Kodak Wratten). All measurementswere carried out in the dark-adapted state and stimulus luminance ranged from b-wave threshold to saturation (l.5*10-2-2.4 cd+/m2) using a 150 W Xenon flash light (lambda= 508 nm; duration: 10~sec).
For ACE inhibition Quinapril (Parke-Davis) disolved in 0.9'%saline was intravenouslyinjected at a concentration of 4 mg/kg. In five animals the specific bradykinin receptor blocker Hoe140(Hoechst AG) was injected (1 mg/k ) 2 hr prior to ACE inhibition. H6e140(D-Arg-8 .5 [Hyp ,Thl ,D-Tic7,0ic8]-bradykinin)is a highly potent, competitiveBK antagonist,specificto BK receptors and with no intrinsicactivity Wirth et al., 1991) . Electrophysiologicaldata were recorded several times before and after applicationof the drugs. Statistical analysis was performed using the non-parametric Wilcoxon test.
RESULTS

Arterial blood pressure
The ACE inhibitorQuinaprilregularlycaused a drop in mean arterial blood pressure (MAP), irrespective of the presence of Hoe140. The relative reduction in MAP was greatest (42~17 mmHg) at 90 min after the injection and lasted for another 30-60 min. Hoe140,on the other hand, did not lead to MAP changes.
Scotopic b-wave
The effects of the ACE inhibitor Quinapril and the speci"fic BK receptor blocker Hoe140on the scotopic bwave amplitude are demonstrated in Fig. 2 . The amplitudes of the b-waves were plotted against the logarithm of integral luminance of the stimulus, presented for 17)psec at a fixed stimulus interval of 5 sec after dark adaptation for at least 90 min. The intensityresponse functions (V -logI) obtained before drug application (solid circles) follows a typical sigmoidal course. An increase of irradiancebeyond 2 or 3 log units abovethe b-wave threshold, producesa dmp in amplitude between two rising phases. The second rising phase is considered to be generated by cones (Arden et al., 1960; van Lith, 1966) whereas the dip between them is thought to be a result of interactions within the rod pathway (Olsen et al., 1986) .Quinaprilresultsin an increaseof the b-wave amplitude.The V -logI functionalso shiftsto the left and becomes steeper [diamonds in Fig. 2(a) ]. Both effects indicate an overall increase in sensitivity(0.5 log units) and gain (5070). Changes in amplitude were significant (P < 0.05). These results are indicative of an ANGII involvementin affecting the scotopic b-wave amplitude.However,the broad substratespecificityof the ACE raises the question of an involvement of various other ACE substrates. As ACE inhibition not only reduces the ANGII activity but also increases the BK concentration via reduced BK inactivation, in a second series of experiments we injected the BK receptor blocker HoelAOprior to ACE inhibition [ Fig. 2(b) ].
Hoelqo is a competitive receptor blocker with a high affinity to BK receptors. The systemic halftime value exceeds 4 hr .The injectionof Hoe140 itself does not affect the scotopic b-wave amplitude [diamonds in Fig. 2(b) ]. However, subsequent ACE inhibition leads to an increase in amplitude comparable with those experimentswhere no BK receptorblockerhas been applied [solid triangles in Fig. 2(b) ]. Consequently, effects of ACE inhibition on the ERG amplitude under these circumstances are likely to be mediated solely via the RAS without involvementof BK. The implicittime of the scotopicb-wave shows a quite different behaviour (Fig. 3) . ACE inhibitionshortensthe implicit time as one could expect from the amplituderise in Fig. 2 . Responseselicited 2.5 log units above threshold are reduced by Quinapril by approximately 119%[solid diamonds in Fig. 3(a) ]. The difference is statistically significant (P < 0.05). Responses obtained at lower stimulus irradiances are not affected significantly. In contrast to the b-wave amplitude, the implicit time is altered by Hoe140application. The implicit time of the whole V-logI function is reduced significantly (P < 0.05) by Hoe140[diamonds in Fig. 3(b) ]. Subsequent ACE inhibition does not result in further changes [solid triangles in Fig. 3(b) ]. In summary, the BK receptor blockade does not affect the scotopic b-wave amplitude, nor does it change the Quinaprilinduced effect on the bwave amplitude.However, there is a marked influenceof Hoe140on the implicit time, strongly suggesting a BK involvement in the time domain of ERG b-wave generation.
Scotopic a-wave
At a stimulusluminanceof 2.4 cd/m2,influenceson the scotopic a-wave were also evaluated. Before drug application mean ( + SD) amplitude and implicit time were 175 i 23 pV and 13 + 1.3 msec, respectively.The course of the a-wave remains unaltered throughout the entire experiment. The,a-wave reflecting activity of the outer retina is not affected by ACE inhibition, BK receptorblockadeor by the combinationof Quinapriland Hoelqo application. This observation might point to a specific influence of the pharmacological alterations on the different layers of the retina.
Hertz jlicker
In order to obtain a cone responsewithout exposureto extensive light adaptation, a 30 Hz red flicker was recorded. Prior to drug administration, amplitude and implicit time are 14.6,aV (-J 4.7 pV SD) and 59.3 msec (+ 12.4 msec SD), respectively. The 30 Hz flicker amplitude and latency were not affected by ACE inhibition,BK receptor blockade or by the combination of Quinapriland Hoe140application.The data from the 30 Hz red flicker response indicate that the cone pathway is not as involved in a hypothetical RAS-mediated neuromodulatoryprocessin the retina as the rod pathway.
DISCUSSION
The present results support the evidence that the observed effects of intravenously applied bradykinin inhibitor Hoe140and subsequentACE inhibitionQuinapril on the cat electroretinogram represent actions of modulation within the angiotensin-bradykininmetabolism on retinal neurotransmission. We previously reported that ANGII is present in the neuroretina,affecting amplitude and implicit time of electroretinographic responses (Zrenner et al., 1989; Jacobi et al., 1994) . In the present study we have extended those findings by recording ERG responses under specific BK receptor blockade,supportingthe notion of a RAS involvementin retinal neurotransmission.Both BK, as well as ANGII, are substratesof ACE-thekey enzymeof the RAS-and have been reported to occur in various ocular tissues of human, feline, bovine and cat (Ferrari-Dileoet al., 1988; Kaelin et al., 1994) . Undoubtedly, there is evidence (Igemoto & Yamamoto, 1978; Igic & Kojovic, 1980) indicating that an ocular renin-angiotensinsystem may exist. However, the precise localization of the components of the RAS and the sites for synthesisand activity still remain unclear, especially concerning neuroretinal activity (Ferrari-Dileo et al., 1987 Danser et al., 1989; Strittmatteret al., 1989; Deinum et al., 1990) .
In a previous study, inhibitionof ACE by Quinaprilin anaesthesized cats resulted in distinct changes of ERG responsesoriginatingin the inner retina, which were to a certain extent reversible on ANGII supplementationand not explainedby its effectson the vascularsystem (Jacobi et al., 1994; Demant et al., 1982; Niemeyer et al., 1982) . Signals originating in the outer retina (PIII) remained unaffected (Jacobi et al., 1994) . This strongly points towards a modulatory effect of ANGII on retinal neurotransmission. Since ACE converts a number of substrates it is conceivable that other substrates such as BK may also be present in the neuroretina, thereby characterizingACE rather than other substratesas being of importance in the course of modulating retinal processing.
The present results support this hypothesis. The application of a specific BK blocker (Hoe140)does not affect the a-wave but has some effect on the b-wave. Depolarizing bipolar cells possibly are the neuronal origins of this response and, therefore, ought to be considered as a probable site of action. However, effects on the b-wave implicit time could also be interpreted as amacrine cell-mediated. Subpopulations of amacrine cells increase the time course of rod signals (Nelson, 1982) . Again there is immuncytochemical evidence to supportthese assumptions,since specificANGII binding sites have been revealed in a subpopulationof amacrine cells in chicken .
An influenceof bradykininon the depolarizingbipolar cells has to be considered in conjunction with Miiller cells, sinceboth contributeto the formationof the b-wave (Miller & Dowling, 1987) . The Mi,illercell/K+-hypothesis of b-wave generation implies that the light-evoked increase in extracellular [K+] in the outer and inner plexiform layers results in an influx of [K+] into Muller cells, which in turn resultsin a radial currentflowthrough the cells that can be picked up by corneal electrodes (Miller & Dowling, 1987; Kuffler, 1967; Faber, 1969) . The [K+] increase in the outer plexiform layer is mainly generated by the depolarizingbipolar cells and predominates in generatingthe response (Faber, 1969; Dick et al., 1985; Stockton & Slaughter, 1989) . Thus, the b-wave may reflect indirectly the activity of the depolarizing bipolar cells and the observed alterations could be explained by some kind of neuronal influence of the RAS on these cells.
However, since IK+]-metabolismin the Miiller cell is most probably responsiblefor the b-wave modulationof Mi.tilercell function itself, alterationsshould show up in the ERG (Kuffler, 1967) . Neuropharmacologicalactions on Mi.illercells would alter neurotransmission in the retina as well, but in a more global manner since glial cells rather than individualneurons are involved.A glial cell-mediated mechanism on the extracellularpotassium level, therefore could play a role in the BK effect as well.
The probability of the observed ERG alterations simplybeing due to variationsin systemicblood pressure is very low. Demant et al. (1982) convincingly showed that variations in the systemic arterial blood pressure have no effect on the b-wave of the cat electroretinogram. Autoregulation of retinal circulation has therefore been postulated . We confirmed these results by reducing the mean arterial blood pressure (MAP) by means of dihydralazine injections (Jacobi et al., 1994) ; ERG responses remained stable even when lowering the MAP to 60 mmHg. This notion of a MAPindependent influence is further supported by the observation that the a-wave-representing activity in the outer retina-is not affected by changes in BK or ANGII activity, while responses generated in inner retinal layers (b-wave) are influenced., Finally, it should be mentioned, that in spite of the presumed autoregulation, a local ocular circulation-retinal or choroidal in particular-could theoreticallybe affected by the applied neuropeptides, which would occur undetected by our experiments.
In summary, the results presented here support a hypothesisof RAS involvementin retinal neurotransmission that is not linked to its systemic vasoactive effects, since: (1) inner retina (b-wave) and not outer retina responses (a-wave) are affected; (2) subsequent to previously reported ANGII effects we can now report on experiments with a BK-mediated influence on mammalian ERG with no effects on systemic blood pressure;(3) the amplitude-increasingeffect of Quinapril is not alteredby previousBK receptorblockade;(4) these results are in accordancewith immunohistochemicaland in vitro electroretinographicstudies that point to inner neuroretina involvement.Whatever the possible cellular origin mightbe, these in vivo experimentsfurther support evidence of the renin-angiotensinsystembeing involved in retinal neuromodulation, which shows up in the Ganzfeld ERG.
